suberoyl bis-hydroxamic acid has been researched along with Friedreich Disease in 1 studies
suberoyl bis-hydroxamic acid: antineoplastic, Histone Deacetylase inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herman, D | 1 |
| Jenssen, K | 1 |
| Burnett, R | 1 |
| Soragni, E | 1 |
| Perlman, SL | 1 |
| Gottesfeld, JM | 1 |
1 other study available for suberoyl bis-hydroxamic acid and Friedreich Disease
| Article | Year |
|---|---|
Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia.
Topics: Acetylation; Alleles; Anilides; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme | 2006 |